New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Cabenuva cabotegravir and rilpivirine Click here for more information |
ViiV Healthcare | A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection. |
|
Cosela trilaciclib Click here for more information |
G1 Therapeutics | A kinase inhibitor to decrease the incidence of chemotherapy-induced myelosuppression. |
|
Evkeeza evinacumab-dgnb Click here for more information |
Regeneron | A monoclonal antibody for homozygous familial hypercholesterolemia. |
|
Lupkynis voclosporin Click here for more information |
Aurinia Pharm. | A calcineurin-inhibitor immunosuppressant for active lupus nephritis. |
|
Tepmetko tepotinib Click here for more information |
EMD Serono | A kinase inhibitor for metastatic non-small cell lung cancer. |
|
Ukoniq umbralisib Click here for more information |
TG Therapeutics | A kinase inhibitor for marginal zone lymphoma and follicular lymphoma. |
|
Verquvo vericiguat Click here for more information |
Merck | A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%. |
|
Vocabria cabotegravir Click here for more information |
ViiV Healthcare | An HIV-1 integrase strand transfer inhibitor for short-term treatment of HIV-1 infection. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Posimir bupivacaine Click here for more information |
Durect Corp. | New formulation local anesthetic for infiltration use. |
| Brand/Generic | Company | Description |
|---|